BioXcel Therapeutics, Inc. BioXcel Therapeutics, Inc.

  • About
    • Overview
    • Management Team
    • Board of Directors
    • Strategic Advisors
  • Product Pipeline
    • Overview
    • Expanded Access
  • News & Media
    • Press Releases
    • Publications
    • Events
    • Media
  • Investors
    • Investor Relations
    • Overview
    • News / Events
    • Overview
    • Press Releases
    • Press Coverage
    • IR Calendar
    • Email Alerts
    • Company Info
    • Overview
    • Presentations
    • Management Team
    • Contacts
    • FAQ
    • Financial Info
    • Overview
    • Balance Sheet
    • Income Statement
    • Cash Flow
    • Financial Results
    • Stock Data
    • Overview
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
    • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
    • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • Business Development
  • Careers
    • Overview
    • Job Openings
  • Contact

Press Releases

News & Media

News & Media

  • Press Releases
  • Publications
  • Events
  • Media

UPDATE -- BioXcel Appoints Eric K. Rowinsky, M.D. to its Board of Directors

Jan 5, 2017

BioXcel Appoints Eric K. Rowinsky, M.D. to its Board of Directors

Jan 5, 2017

BioXcel and Centrexion Therapeutics Further Advance Big Data Innovation Lab Collaboration in Chronic Pain

Oct 19, 2016

BioXcel Appoints Dr. Peter Mueller as Chairman of Scientific Advisory Board

Oct 12, 2016

BioXcel’s BXCL101, Receives Orphan Drug Designation from the U.S. FDA for the Treatment of Patients with Neurofibromatosis Type 2 (NF2)

Sep 13, 2016

BioXcel Begins Strategic Collaboration with Alnylam to Discover Novel RNAi Therapeutic Products

May 24, 2016

BioXcel to Present at the 3rd International Conference on the Progress of Regenerative Medicine and its Cultural Impact at the Vatican

Apr 27, 2016

BioXcel Expands Into CNS Orphan Disease Therapeutics

Feb 8, 2016

BioXcel Strengthens Position in Immuno-Oncology With Dedicated Big Data Analytics Platform

Jan 21, 2016

BioXcel and Centrexion Partner to Develop Novel Chronic Pain Therapies

Jan 11, 2016
    • 1...
    • 6
    • 7
    • 8
    • 9
    • 10
    • 11
    • 12
    • 13
    • 14
    • 15
    © 2021 BioXcel Therapeutics, Inc. All Rights Reserved.
    Privacy Policy Disclaimer Sitemap